Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Why Researchers and Health Scientists Are Turning Their Attention to Peptides

For most of the last hundred years, drug research has basically run on two tracks. On one side you had small molecules, which is your classic pill like aspirin, and on the other…

PR
By Priya Raman · Science Reporter
Oct 12 06:42 ETSource: UrbanMatter

From the source

Why Researchers and Health Scientists Are Turning Their Attention to Peptides

For most of the last hundred years, drug research has basically run on two tracks. On one side you had small molecules, which is your classic pill like aspirin, and on the other you had the big biologics such as antibodies. Peptides sort of sat between the two and, for a long while, nobody got too excited about them. That’s changed a lot, and if you wandered into a pharmacology lab today I’d bet t

Read at urbanmatter.com
PeptiPrescribed peptides from $99/moSee all →